- 8 health system, hospital CMO and CNO exits in 2026
- 10 new medical schools announced in 2026
- Physician-owned assisted living facility opens in Utah
- Leadership in the Age of Learning
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- Massachusetts moves to restrict kratom sales
- 1 dead in officer-involved shooting at Alabama hospital campus
- Cyclosporiasis admissions top 700: 4 things to know
- The value of ‘prosocial grand ambition’
- Meet the leaders of the fastest-growing dental practices
- WISeR’s high-stakes first year, in 8 questions
- Health system CEO pay in 2026: 6 trends to know
- 10 states with the biggest population gains and losses
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Will cardiology’s ASC strategy pay off? CVL’s new CEO is betting on it
- 5 numbers making dentists optimistic
- 25 state behavioral health policy updates
- Wisconsin woman accused of posing as fake dentist ordered to pay customer $144K
- Physician independence is making a comeback — why ASCs are leading the way
- Surgery Partners is betting on physician recruiting, not M&A, for growth: 5 things to know
- Dentists battle insurance woes: 5 updates
- Philadelphia dentist dies at 86
- 4 injured after car crashes into North Carolina pediatric dental office
- Ellis Hospital sues St. Peter’s over cardiologist noncompetes, warns of $75M revenue risk
- Mental healthcare provider gaps, by state
- Park Dental Partners posts $66.2M in Q2 revenue
- 28 new behavioral health study findings to know
- 23 new behavioral health projects to know
- Which services are hit hardest by CON?
- 5 gastroenterologists in the headlines
- Where spine, orthopedic ASCs are gaining ground
- Aspen Dental continues 2026 growth with new Chicago practice
- Major PBMs agree to offer TrumpRx pricing information to members
- Distalmotion gets FDA clearance for hernia repair system
- NYC Health + Hospitals adds $600K ophthalmology microscope
- Providence reports $400M operating improvement halfway through 2026
- A look at where Aetna is seeing value-based care success in Medicare Advantage
- Nationwide program to quit smoking would save US $12B: Study
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- Angelalign to appeal court’s decision in clear aligner patent infringement case
- It's crunch time for Karyopharm as company faces potential default next month
- UNC Health Pardee completes 23-bed behavioral health center
- Oregon State Hospital superintendent out after less than a month
- Nebraska ASC inks prime vendor agreement with Medline
- Affordable Care completes recapitalization, enters ‘next chapter’ of growth
- March of Dimes: Maternity care deserts persist, Medicaid cuts threaten to curb access further
- Trump administration refers scores of providers, pharmacies, PBMs to DOJ, OIG over past billing for pediatric gender-affirming care
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- Abbott to pump up blood supply with $1M college sports prize amid US crisis
- Federal agencies release ‘Treatment First’ toolkit
- California moves 15 behavioral health projects forward
- Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flags
- Appeals court tosses methodology for calculating NSA qualifying payment amounts
- UC San Diego Health, West Health launch $40M accelerator for 'tech-forward' coordinated care
- Epic releases Care Everywhere diagnostic image exchange to tackle healthcare's 'CD problem'
- FDA Wants More Information From Food Makers On New Food Chemicals
- Cityblock unveils partnership with Humana in North Carolina
- Antelope Recovery, offering SUD care for teens, to expand Spanish services in Colorado
- Legend interim CEO talks rising competition as Carvykti maker posts first profit
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Cedar launches Kora Platform to build out agentic AI for medical billing
- Sharp HealthCare announces another reorganization affecting 260 workers
- Alfasigma gains arthritis drug, access to new markets with M&A play
- Common Health Coalition secures $100M from OpenAI Foundation to boost hepatitis C cure rates
- Lilly takes 6 companies to court for selling retatrutide knockoffs
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Suvi Health launches ambient AI solution for patients to reduce hospital stays and support care transitions
- The biggest payer and provider trends from Q2
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Hospitals Say They Found a Tool To Help Reduce Childbirth Risks: Wristbands
- Years After He Quit Smoking, a Lung Cancer Scan Saved His Life
- Hospital Prepayment Requirements Add New Wrinkles to Patients’ Financial Responsibility
- Fresenius pulls one batch of Actemra biosim over glass particle concerns
- Oracle Health debuts revamped patient portal with an AI upgrade
- Snapchat creates ad format to support pharma disclosure needs
- CMS ends Medicaid, CHIP funding for gender-affirming care for minors
- Healthcare CFOs face growing decision-making expectations. Many say they aren't ready
- Assort Health rolls out AI agent to automate referrals for specialty practices and health systems
- Claims data transparency empowers employers to act on affordability: survey
- Hims & Hers posts $753M in Q2 revenue as it preps for push into peptide market
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Senators introduce bipartisan legislation to further antimicrobial resistance research
- CMS' mandatory VBC programs brought substantial administrative costs for hospitals: study
- Flagler Health secures $50M series B for AI-native MSK care platform expansion
- Attruby cruises toward blockbuster land as BridgeBio CEO spots ‘stabilizer-first’ ATTR market
- WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand
- Barbie And Ken Fade From Fantasy, Offer More Realistic Proportions, Study Finds
- Children Should Get Flu Vaccine, Top Pediatrics Group Recommends
- Together, Two Everyday Health Factors Double Death Risk In Midlife And Beyond
- Many States Cover Doula Care, But Access To A 'Birthing Bestie' Is Often Out Of Reach
- Patients Wary of Governments, Companies Pushing AI as a Rural Healthcare Solution
- A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- Trump signs executive order to overhaul pediatric vaccine recommendations
- Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path
- Jalapeño Recall Reaches Seven Grocery Chains In 26 States
- New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval
- Even Light Exercise May Lower Stroke Risk For People With A-fib
- Working At Home Makes Breastfeeding Harder, Not Easier, Study Says
- Kidney Dialysis: Here's What You Need To Know
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
- Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening
- Bristol Myers Squibb lays out plan for $2.3B manufacturing facility in Houston
- Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics
- Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's
- Budget Battle Erupts In Nation's Capital Over Opioid Settlement Money
- Rising Global Heat Linked To Mental Health Risks In Children
- Quanterix hires GE Healthcare, Exact Sciences alum as chief commercial officer
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- FDA Reverses Course, Approves First mRNA Flu Shot
- Therapy Dogs Aid Stroke Rehab
- Can Yoga Calm A Grumpy Gut?
- Review Finds Little Proof IVF Embryo Transfer Tricks Boost Success
- Short-Term Vegan Diet Linked To Lower Inflammation And Aging
- Medicaid Work Rule Leaves Homeless People In The Cold
- Wildfire Smoke An Increasing Hazard To U.S. Pregnancies, Study Says
- Salmonella Outbreak Linked To Imported Jalapeños Sickens Hundreds
- Leo Pharma readies rare disease education push for 2nd annual GPP awareness day
- Wildfire Smoke Sends More Oregonians To Emergency Rooms
- Peanut Allergy? Fecal Transplant Might Be A Solution, Pilot Trial Finds
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
Michigan healthcare freedom community forum
Increasing penalties for fentanyl, and classifying them as Schedule I. That class is defined as drugs with no current medical use with high potential for abuse and/or addiction."The ultimate impact of this bill is taking fentanyl permanently away from pain and surgery patients.
What could possibly go wrong?
by Joyce Frieden, Washington Editor, MedPage Today May 26, 2023
The House passed a bill Thursday that proponents say is designed to reduce the number of people who become addicted to fentanyl, but opponents say it won't solve the problem and will just increase the number of people incarcerated for drug-related crimes.
The Halt All Lethal Trafficking of Fentanyl (HALT Fentanyl) Act passed by a vote of 289-133, with 215 Republicans and 74 Democrats voting in favor. The measure would:
- Permanently put fentanyl-related substances into Schedule I of the Controlled Substances Act. Currently, fentanyl is on Schedule I through Dec. 31, 2024, thanks to a temporary scheduling order issued by the Drug Enforcement Administration (DEA).
- Establish a new, alternative registration process for Schedule I research that is funded by HHS or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the FDA.
- Clarify that offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues. For example, offenses involving 100 g or more of a fentanyl-related substance will trigger a 10-year mandatory minimum prison term.
The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain situations, and waiving the requirement for a new inspection in some cases.
"With today's bipartisan vote in the House to advance the HALT Fentanyl Act, we are one step closer to curbing the devastating fentanyl poisoning crisis and saving American lives," Rep. Bob Latta (R-Ohio) said in a statement. "Illicit fentanyl is now the leading cause of death for people in the United States aged 18 to 49 ... This permanent labeling change is significant and needed because it will help get fentanyl-related substances off our streets and out of our communities. I now urge the Senate to take up this bill and send it to the president's desk to be signed into law."
House Speaker Kevin McCarthy (R-Calif.) applauded the bill's law enforcement provisions. "Due to the Biden administration's incompetence at the border, fentanyl has flowed into American communities and destroyed lives," he said in a statement. "The HALT Fentanyl Act is one needed tool to help stop the flow of fentanyl and provides law enforcement agencies the authority they need to help them adequately address this crime."
The Biden administration also praised the bill, specifically the permanent scheduling provision and a provision to make fentanyl research easier. "These two provisions are critical components of the Biden-Harris Administration's 2021 recommendations to Congress to combat the supply of illicit FRS [fentanyl-related substances] and save lives," the White House said in a statement. "The administration calls on Congress to pass all of these critical measures to improve public safety."
But others were not so happy. Despite multiple extensions of the Schedule I designation, "overdoses have not gone down, and we have unfortunately [not] made a dent in the incidence of opioid use disorders," Rep. Frank Pallone, Jr. (D-N.J.), ranking member of the House Energy & Commerce Committee, said on the House floor.
"Fentanyl and synthetic opioids continue to flood into the country. In testimony before our committee, the DEA administrator noted that DEA seized more than 50 million fake pills and 10,000 pounds of fentanyl in 2022 ... The HALT Fentanyl Act is a partisan distraction from the hard, bipartisan work that actually has to be done to address a long standing, intractable problem that faces our communities," he said.
"We simply cannot incarcerate our way out of a public health crisis," Pallone said. "The HALT Fentanyl Act does not provide any resources for research, prevention, treatment, recovery, or harm reduction. It also does not provide law enforcement or public health agencies with any additional resources to detect and intercept illicit drugs entering the country."
Several advocacy groups agreed. "Passage of the HALT Fentanyl Act and the draconian expansion of mandatory minimum sentencing for fentanyl-related substances contained in it would be a reckless repetition of the costly mistakes of the war on drugs that disproportionately impacts Black and Brown communities and creates the conditions for even more harmful illicit substances to enter the drug supply," Drew Gibson, director of advocacy for AIDS United, said in a statement.
"Any hope that we have of ending the overdose, HIV, and viral hepatitis epidemics in the United States lies in an embrace of evidence-based best practices and a rejection of the punitive and racially inequitable policies that have destroyed millions of lives over the last half-century," Gibson added.
"In passing the HALT Fentanyl Act, the House seems intent on doubling down on the same failed strategies that got us here to begin with," Maritza Perez Medina, director of the Office of Federal Affairs at the Drug Policy Alliance, said in a statement. "Increasing criminal penalties and expanding the use of mandatory minimums, as this bill does, has never reduced the supply or demand of illicit drugs. Instead, it only exacerbates racial disparities in the criminal legal system and creates the conditions for an even more unknown, and more potent, drug supply to flourish."
AIDS United, the Drug Policy Alliance, and other organizations are supporting the Support, Treatment, and Overdoses Prevention of Fentanyl Overdoses (STOP Fentanyl Overdoses) Act sponsored by Rep. Annie Kuster (D-N.H.). That bill would expand testing for fentanyl and related substances; increase information-sharing by public health departments and law enforcement in order to identify public health threats and prevent overdoses; and improve access to overdose reversal medications and substance use disorder treatment.
On the other side of the Capitol, the Senate version of the HALT Fentanyl Act was introduced by Sen. Bill Cassidy (R-La.) on March 30. It has been referred to the Senate Judiciary Committee but no other action has been taken on it.
https://www.medpagetoday.com/washington-watch/washington-watch/104730
And not a word about the border.
Joyce Frieden oversees MedPage Today’s Washington coverage, including stories about Congress, the White House, the Supreme Court, healthcare trade associations, and federal agencies. She has 35 years of experience covering health policy.
Michigan testimony on border concerns did contribute to this bill.
The Detroit News in February highlighted Rebecca Kiessling. New Detroit Congressman Shri Thanadar gets a line at the end.
'You're not protecting our children': Rochester Hills mom testifies about 2 sons' fentanyl deaths
Feb. 28, 2023Washington― A Michigan mother tearfully told House lawmakers the story Tuesday of her two sons' deaths from an accidental overdose of the opioid fentanyl, saying the government isn't doing enough to combat the opioid crisis and halt illegal drugs at the border.
"My children were taken away from me," saidRebecca Kiessling, a family law attorney and conservative activist from Rochester Hills.
"This should not be politicized. It's not about race. Fentanyl doesn't care about race. You talk about welcoming those crossing our border seeking protection? You're welcoming drug dealers across our border. You're giving them protection. You're not protecting our children."
Kiessling said her two sons, Caleb, 20, and Kyler, 18, died July 29, 2020, from fentanyl poisoning, along with 17-year-old Sophia Harris, when they took what they thought were Percocet pills that turned out to contain the drug fentanyl, a potent synthetic opioid drug that can be lethal in tiny amounts.
She said her sons' "dealer" was saved by a dose of the overdose-reversing spray Narcan and is serving prison time. Lorenzo Brabo was sentenced in 2021 to eight to 15 years in prison for providing the fentanyl that led to the three overdose deaths, according to reports.
"I don't use the term 'drug overdose' because this was not an overdose. This was murder," she said. "This is a war. Act like it. Do something."
Kiessling testified Tuesday morning before the Republican-led U.S. House Committee on Homeland Security, urging Congress and the White House to take the flow of illegal drugs over the Southern border more seriously. Prior to her sons' deaths, Kiessling said she didn't know what fentanyl was.
"I had heard of the opioid epidemic. I thought, you know, people are getting prescription drugs and getting addicted and then getting it on the streets, and that it affects their ability to work. I didn't know that people were dying," she said.
"I didn't know that my boys were taking anything that could kill them. They didn't think that they were either. They thought that they were safe with pills. ... But the government knew. The government's known for years and years."
Opioid overdose trends
Michigan experienced a 23% increase in opioid-related deaths from 1,768 in 2019 to 2,171 in 2020, when Kiessling's two sons died, according to state Department of Health and Human Services' statistics. The number rose to 2,539 deaths in 2021, a 17% jump. U.S. opioid-related deaths rose from 68,630 in 2020 to 80,411 in 2021, according to theNational Institute on Drug Abuse.
Kiessling highlighted the tally of drug-related deaths the year that Caleb was born — 20,000 in 2000 — and the surge of 100,000 like deaths in 2020.
"If we had Chinese troops lining up along our Southern border with weapons aimed at our people, with weapons of mass destruction aimed at our cities, you damn well know you would do something about it," she said.
"We have a weather balloon from China going across the country. Nobody died, and everybody's freaking out about it. But 100,000 die every year, and nothing's being done. Not enough is being done."
Kiessling started crying as she read from a paper written by Kyler weeks before his death, advising to "stay away from drugs and alcohol."
"It's not worth it," he wrote.
Kyler, who had graduated from high school the day before his death, also wrote in a list that he wanted to start working more to stay focused, have a better relationship with his parents, to report to all drug tests and "find another method to cope that works for me," according to his mother.
Caleb, Kiessling said, had started speaking in schools to encourage kids not to try drugs. He wrote a testimony to share with them, saying that he'd "dabbled" in drugs but had stayed away from crack and heroine because he'd grown up "watching my birth mother ruin her life and watch all her friends pass away from heroin overdoses."
Kiessling said later in the hearing that the boys' birth mother died six months after they did.
Lawmakers respond
Committee Chairman Mark Green, R-Tennessee, blamed the Biden administration for border policies that he said have contributed to the "surge" in migrants at the border, "and the drug cartels have taken advantage of the situation."
Kiessling's sons died in 2020, when Donald Trump was president and was trying to extend a wall across the Southern border.
The Biden administration has touted itsoverdose epidemic strategy, which has included spending $1.5 billion on grants for aid to treatment programs and law enforcement. The U.S. Department of the Treasury is using sanctions to target the global fentanyl supply chain, especially in Mexico, administration officials have said.
The Biden administration in February also proposed a rule that migrants seeking to enter the United States will be assumed inadmissible if they "circumvent available, established pathways to lawful migration," including entering the country between ports of entry or arriving at a port of entry without a scheduled appointment.The proposal also rejects those who fail to seek protection in countries through which they pass while heading to the United States.
Green asked Kiessling how her community has been affected by the opioid crisis. She replied that some parents and siblings whom she knows from support groups had committed suicide.
"It's devastating families," she said. "It's been very difficult for my (three) daughters. One daughter, she went off to Michigan State and came home after a semester. It was just too painful."
One of Kyler's friends approached her at a restaurant last summer and said he'd stopped doing any kind of drugs in response to his death, Kiessling said.
"He said, 'I want you to know that your son's death started a movement in our hometown, so that when people show up with pills, they're ostracized, and they're condemned,' he said," Kiessling recounted. "But, you know, for how long? How many of the kids in the high schools now know about my son's deaths?"
Rep. Marjorie Taylor Greene, R-Georgia, also lamented the surge in fentanyl deaths, saying it's become a top cause of death for Americans ages 18 to 45 years old.
"This is unforgivable," said Greene, thanking Kiessling for sharing her story and saying her sons' deaths "should never have happened."
Kiessling responded in part by criticizing witness testimony from the Cato Institute's David Bier, who suggested that policymakers should focus on demand and not supply to reduce drug deaths.
"What I'm hearing him saying is, 'They asked for it.' Seriously, are you kidding me?" Kiessling said. "We need to protect our children. They didn't ask for that. This wasn't demand that they wanted the fentanyl. They thought they were getting Percocet, OK?"
Rep. Donald Payne Jr., D-New Jersey, said most illegal drugs are smuggled through ports of entry into the United States "unfortunately" by U.S. citizens, and usually hidden in vehicles, cargo, or on a person in the hopes "it won't be detected."
Payne suggested lawmakers should focus on what policy changes can be made to allow personnel at ports of entry to focus on the interdiction of drugs.
It was the first full committee hearing for freshman Rep. Shri Thanedar, D-Detroit, a former businessman and Indian immigrant who spoke of the importance of the Northern border.
"Unfortunately, a shortage of pathways for immigration has made our borders very difficult to manage. CBP has had to rely on temporary duty assignments to surge employees where they are most needed, which has often pulled resources away from the northern border," Thanedar said. "As an immigrant myself, I'm a proud example of how immigrants contribute to American society."
Melissa Nann Burke covers Washington for The Detroit News, including Michigan's congressional delegation, the White House and U.S. Supreme Court.
Three years later we finally have the truth about fentanyl.
‘We Walk Fentanyl’: 3rd Whistleblower Emerges in DOJ Probe of Biden-Era DEA Scandal
Fred Lucas | August 4, 2026
A third whistleblower came forward about a Biden-era operation involving alleged massive shipments of fentanyl into the United States that federal agents were told to track and not seize.
The U.S. Justice Department is conducting an internal probe of the operation that critics say likely led to numerous deaths. The most recent whistleblower complaint details a November 2022 fentanyl delivery from Arizona to New Mexico where Drug Enforcement Administration agents were told to monitor the shipment but not arrest anyone.
“Agents believe the courier made a minimum of at least five large deliveries over the following months, each time bringing 50,000-100,000 fentanyl pills and 20-40 pounds of methamphetamine per trip,” the complaint says. “The DEA did not arrest the courier until June 2023; at that time, agents found him with 19 kilograms of methamphetamine and 7 kilograms of fentanyl.” According to the DEA, as few as 2 milligrams of fentanyl can be lethal depending on a person’s body size and tolerance, and 1 kilogram of fentanyl has the potential to kill 500,000 people.
The new complaint also notes that during a training session, one DEA agent dismissed concerns about the operation, saying, “We walk fentanyl,” but adding that federal prosecutors were aware of it.
The complaint comes after the U.S. Justice Department’s Office of Inspector General interviewed two other whistleblowers—former DEA Special Agent David Howell and financial investigator Kevin Small, who worked as a contractor for the DEA’s Albuquerque office—on Friday and Monday, respectively.
Howell was the first to blow the whistle on the operation, alleging that the DEA allowed hundreds of thousands of fentanyl pills into New Mexico because Justice Department prosecutors wanted to track the shipments and bring a bigger criminal case against traffickers. Former U.S. Attorney for the District of New Mexico Alex Uballez oversaw the program, Howell said. Uballez publicly defended the operation, telling The Associated Press it saved lives, was key to intelligence gathering on drug traffickers, and that “the bigger fish are worth catching.”
Howell also alleged that he faced retaliation by DEA officials for exposing the program.
The new 20-page complaint is from a DEA special agent whose name is redacted in the document released by his attorney. Similar to Small’s complaint, the third whistleblower alleges retaliation by Jeffrey Armijo, the assistant special agent in charge of the DEA’s Albuquerque office.
In a March 28, 2025, conversation detailed in the complaint, Armijo screamed, “This is a one way conversation and this stays within my office.” The complaint alleges Armijo threatened to have the whistleblower moved to a different office and said, “I will ice you like Dave [Howell] where you will not work another case again.”
2026-08-03_TL_to_OSC_-_PPP_Complaint__redacted,_no_attachments_Download
Empower Oversight, a whistleblower advocacy group representing all three whistleblowers, sent the new complaint to the Office of Special Counsel late Monday afternoon and forwarded it to the Justice Department’s Office of Inspector General. The offices have the unredacted version of the complaint.The Daily Signal contacted the press office at DEA headquarters in Washington and left a voicemail with the DEA district office in Albuquerque but did not receive a response before publication. The Daily Signal contacted the office of the New Mexico Attorney General but did not receive a response before publication.
‘Fast and Furious’ Comparisons
The operation has invited comparisons to an Obama administration program of the Bureau of Alcohol, Tobacco, Firearms and Explosives, in which gun shipments were allowed to travel into Mexico; two of the guns were found at the scene of the killing of a U.S. Border Patrol agent.Interestingly, the whistleblower complaint notes that the U.S. Justice Department Office of Enforcement Operations conducted a May 9, 2024, training session that included a reference to Operation Fast and Furious. This prompted Howell to raise concerns about the DEA’s program, the new complaint says.
“When the OEO attorneys opened for questions toward the end of the training, SA Howell raised his hand and commented that he believed the Albuquerque District Office needed more training on risk mitigation and expressed concern that OEO, and therefore the Criminal Division’s DAAG, wasn’t being notified regarding the amount of fentanyl that was being allowed to walk in Albuquerque,” the complaint says. “An agent from Group 3 interrupted, saying, ‘We walk fentanyl and our AUSAs are aware.’”
AUSAs are assistant U.S. attorneys, in this case, working under the U.S. attorney for the District of New Mexico.
A 2024 Justice Department Office of Professional Responsibility report said agents had “discretion” in deciding when to seize drugs.
While previous whistleblower complaints said the New Mexico fentanyl walking began in 2023 and ran into March 2025, during the first months of the Trump administration, the new complaint details conversations and confrontations between the whistleblower and his supervisors, namely Armijo, well into 2026.
State Investigation
Tristan Leavitt, of Empower Oversight, told the Daily Signal the U.S. Justice Department has asked his clients not to work with New Mexico state investigators for the time being.New Mexico Attorney General Raúl Torrez this week turned up the heat on the U.S. Justice Department, challenging the agency’s refusal to cooperate with state investigators.
Torrez said in a letter to First Assistant U.S. Attorney Ryan Ellison for the District of New Mexico that his office is “investigating the decisions and conduct of the DEA that resulted in a significant quantity of fentanyl unseized on the streets and in the communities of New Mexico.”
“I further previously explained that the investigation requires access to the full record of the DEA’s activities, operational guidance, and changes to operational guidance in order to assess the lawfulness of these practices,” he continued. He later added, “To that end, NMDOJ seeks to review USDOJ protocols governing fentanyl seizure decisions, and protocols that were apparently rewritten in 2024 to afford agents greater discretion on the timing of fentanyl seizures.”
In a July 29 letter, Ellison told Torrez the Justice Department must regulate access to government information contained in its files or obtained by its employees during the scope of their official duties. Further, it said the U.S. Justice Department cannot be compelled to respond to a demand for documents if it is not a party in the case.
The Daily Signal reached out to the Justice Department Tuesday afternoon but did not immediately receive a comment.
A DOJ spokesperson commented to the Daily Signal on the matter in June. “The alleged conduct occurred under the Biden Administration’s disastrous open border policies. The Trump administration has closed the border and is aggressively pursuing drug traffickers,” the DOJ spokesperson said in a June statement. “DEA Administrator Cole has requested an independent DOJ-OIG review of DEA’s actions in light of this reporting to reaffirm the public’s confidence in our law enforcement agencies. Should that review identify areas of improvement, the DEA will of course implement changes to better their practices.”
“This success has been achieved less than two years into this Administration. We welcome a partnership with Governor Lujan Grisham, as well as New Mexico state and local leaders, to fight the scourge of fentanyl and keep her constituents safe,” the spokesperson added.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























